DeepMed Research

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer

Phase 3

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Drug: DCS (D-Cycloserine ) + Prolonged Imaginal Exposure
Drug: Placebo (sugar pill) + Virtual Reality Exposure
Drug: Placebo + Prolonged Imaginal Exposure
Drug: DCS (D-Cycloserine ) + Virtual Reality Exposure

First Posted Date: 2011-05-12

Last Posted Date: 2019-07-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 192

Registration Number: NCT01352637

Locations: 🇺🇸
VA Long Beach Healthcare System, Long Beach, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
University of Southern California, Los Angeles, California, United States

and more 2 locations

Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: plerixafor
Drug: decitabine

First Posted Date: 2011-05-12

Last Posted Date: 2018-07-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 71

Registration Number: NCT01352650

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Home-delivered Intervention for Depressed, Cognitively Impaired Elders

Not Applicable

Completed

Conditions: Depression
Geriatrics
Dementia

Interventions: Behavioral: Problem Adaptation Therapy (PATH)
Behavioral: Supportive Therapy

First Posted Date: 2011-05-09

Last Posted Date: 2018-03-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 134

Registration Number: NCT01350349

Locations: 🇺🇸
Weill Cornell Medical College, White Plains, New York, United States

Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: CW 002

First Posted Date: 2011-04-20

Last Posted Date: 2014-02-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 136

Registration Number: NCT01338935

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study

Phase 4

Conditions: Thalassemia Major

Interventions: Drug: Placebo
Drug: Vitamin D3

First Posted Date: 2011-03-25

Last Posted Date: 2011-04-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 40

Registration Number: NCT01323608

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Effectiveness of Celecoxib After Surgical Sperm Retrieval

Not Applicable

Terminated

Conditions: Pain

Interventions: Drug: Sugar Pill
Drug: Celecoxib

First Posted Date: 2011-03-25

Last Posted Date: 2018-10-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 78

Registration Number: NCT01323595

Locations: 🇺🇸
Department of Urology, Weill Cornell Medical College,, New York, New York, United States

Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)

Phase 2

Withdrawn

Conditions: Severe Sepsis
Acute Respiratory Distress Syndrome

Interventions: Drug: Placebo
Drug: Bevacizumab

First Posted Date: 2011-03-14

Last Posted Date: 2016-05-03

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT01314066

Locations: 🇺🇸
Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, United States

Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer

Not Applicable

Terminated

Conditions: Pancreatic Cancer
Cholangiocarcinoma

Interventions: Device: Endoscopic bipolar radiofrequency probe (ENDOHPB)

First Posted Date: 2011-02-24

Last Posted Date: 2017-05-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 29

Registration Number: NCT01303159

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus

Phase 2

Withdrawn

Conditions: Esophageal Cancer

Interventions: Device: HANAROSTENT TM covered Esophageal Stent

First Posted Date: 2011-02-23

Last Posted Date: 2015-06-03

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT01301495

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Personalized Antidepressant Adherence Strategies For Depressed Elders

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: TIP

First Posted Date: 2011-02-23

Last Posted Date: 2017-01-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 231

Registration Number: NCT01301859

Locations: 🇺🇸
Weil Cornell Medical College, New York, New York, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy